Vascular Ultrasound Interpretation Course - Oct 7-8, 2021
|IMPORTANT BROWSER INFORMATION|
This site will not work on Internet Explorer 8. Please download one of the preferred browsers:
The course will begin with hemodynamics, pathophysiology, and state-of-the-art Doppler instrumentation.
The majority of the course will focus on interpretation of vascular studies and case analysis of cerebrovascular, peripheral arterial, peripheral venous and abdominal Doppler studies. The course will also include some of the more unusual findings in vascular disease. Informal question and answer sessions will be incorporated throughout the program to facilitate a high level interactivity between participants and faculty. Course participants are invited to bring their interesting or challenging cases.
For those with minimal or no prior experience with vascular technology, we recommend the Vascular Ultrasound-Core Course.
To register for this course, go to the Jefferson Ultrasound Radiology Education Institute webpage.
To successfully complete this activity, the required evaluation must be completed no later than Monday, November 22, 2021. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.
This advanced course is designed for physicians and sonographers who have been practicing noninvasive vascular diagnosis. The course will assume that participants have an understanding of anatomy of the vascular system, principles of Doppler ultrasound and the basic principles of Doppler diagnosis.
After completing this educational activity, learners will be able to:
- Identify the key information required in a vascular study.
- Compose a report of a vascular study.
- Describe the components of a vascular report.
- Demonstrate improved case interpretation ability.
This educational activity has no commercial or in-kind support.
Recording and Photography Strictly Prohibited
Unauthorized recording or photography at a Jefferson-sponsored event is strictly prohibited. Individuals found violating this policy will be asked to vacate the activity. No credits or refund will be issued.
This is a virtual conference.
Thomas Jefferson University endorses the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards. All planners, faculty, and others in control of educational content are required to disclose all financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity.
Such disclosures will be available prior to the start of the activity. Jefferson Conflict of Interest resolution process may result in changes to the program agenda.
The members of the planning committee have no conflict of interest to disclose.
Levon Nazarian, MD-Course Director
The presenters for this educational activity have no conflict of interest to disclose.
Barbara Alberto, MS, RVT
Philip Bendick, PhD
George Berdejo, BS, RVT
Paul DiMuzio, MD
Traci Fox, EdD, RDMS, RVT
Ann Marie Kupinski, PhD, RVT
Laurence Needleman, MD
All presenters are required to disclose whether their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the US FDA for the treatment of disease(s).
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.
It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.
In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: The Thomas Jefferson University designates this educational activity for a maximum of 16.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals: This educational activity is designated for 16.0 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Daily Credit Breakdown
October 7: 8.00 AMA PRA Category 1 Credits™.
October 8: 7.0 AMA PRA Category 1 Credits™.
Learners may claim .25 one time for the completion of the required evaluation.
The difference between the daily credit and the total credit is due to the allowed rounding in calculating CME credit for the total course.
- 16.00 AMA PRA Category 1 Credit™
- 16.00 Attendance